Using a Polymarket Strategy for Predictive Markets and Forecasting in Healthcare Operations
An interactive PhD-level model that puts the mathematics of prediction markets, ensemble forecasting, and proper scoring rules into the hands of healthcare leaders. Trade a live market maker, stress test it against statistical baselines, and watch where crowd-sourced prices help and where they fail.
A disciplined way to ask whether markets belong in your forecast stack
Prediction markets aggregate distributed expertise through financial incentives, adapting to new information in real time. The central research question is not whether markets are clever, but whether they earn their place alongside the statistical and machine-learning methods that already run your operations.
The central tension
Two recent strands of evidence pull in opposite directions, and an honest framework has to hold both. On one side, ensemble and hybrid methods that combine statistical, machine-learning, and market-based signals generally beat single models. On the other, when prediction markets have actually been tested on healthcare questions (US influenza hospitalizations and measles cases), they underperformed expert ensembles and were beaten by a simple ARIMA baseline, partly because of thin trading volume and structural weaknesses.
What this model lets you do
- Run a live logarithmic market maker and feel how the liquidity parameter changes price sensitivity (tab 02).
- Compare classical, machine-learning, ensemble, and market models head to head (tabs 03 and 04).
- Score any forecast with the Brier and log scores and see calibration on a reliability diagram (tab 05).
- Simulate a high-budget trader distorting a thin market, after Smart and colleagues (tab 06).
- Walk the data pipeline, validation plan, ethics review, and a twelve-month research timeline (tabs 07 through 09).
Why it matters for imaging and operations
Imaging service lines live and die on demand forecasting: scanner utilization, technologist staffing, and same-day capacity all depend on getting next week roughly right. A market that lets schedulers and radiologists express judgment about an unusual referral surge could, in principle, surface information no model has yet seen. The discipline here is knowing when that signal is real and when it is noise dressed as a price.
Trade a logarithmic market scoring rule
Polymarket-style markets use an automated market maker. The most common is Hanson’s logarithmic market scoring rule (LMSR), which guarantees liquidity and bounded loss. Buy and sell shares below and watch the implied probability and your cost move. This is the real engine, not a mockup: prices and costs are computed from the cost function directly.
Price path
Reading the liquidity dial
A small b makes the price jump on every trade: the market is sensitive but easy to move, which is dangerous in thin healthcare settings. A large b yields a sticky market that barely budges unless many shares trade. Try setting b to 20, buying 25 Yes, then doing the same at b = 300 and compare how far the price travels.
The bounded-loss guarantee
The reason platforms favor LMSR is that the operator’s worst-case loss is capped at b · ln(2), regardless of how the market resolves. That predictability is what makes a market maker viable without an active order book. The trade-off is that liquidity is subsidized: someone funds that maximum loss.
The forecasting toolkit, with honest trade-offs
No single method dominates across contexts. The literature is consistent that ensembles tend to win, that classical models stay valuable as interpretable baselines, and that markets sit at the experimental edge.
Relative forecast skill (illustrative)
| Model category | Examples | Strengths | Weaknesses |
|---|---|---|---|
| Classical time series | ARIMA, ETS, Prophet | Interpretable, well understood | Limited nonlinear capture, assume stationarity |
| Machine learning | XGBoost, random forest | Handles complex patterns, many features | Needs large data, less interpretable, overfit risk |
| Deep learning | LSTM, temporal CNN | Captures long-range dependencies | Data hungry, black box, tuning intensive |
| Ensemble | Stacked or bagged blends | Generally most accurate, robust to single-model error | Computationally heavy, less transparent |
| Hierarchical | MinT reconciliation | Coherent across department, hospital, system levels | Complex, needs hierarchical data |
| Agent-based | Patient-flow or trader ABMs | Models interactions, scenario testing | Hard to calibrate, heavy computing |
| Prediction market (AMM) | LMSR-based market | Aggregates expert judgment, real-time updates | Manipulable, needs active traders |
Does the market add information the ensemble lacks?
This simulation reconstructs the logic of Chandrasekhar and colleagues (2026), who compared Polymarket contracts on flu hospitalizations against expert ensembles. Set the simulated trading volume and watch the optimal blend decide how much weight the market deserves. At realistic (low) volume, the answer trends toward zero.
Forecast tracks vs the truth
Accuracy by method (Brier)
What the original study found
Across real flu and measles contracts, the market matched only the weaker individual models and was outperformed by a simple ARIMA baseline. It displayed implausible probabilities, including mass on impossible future values, on very low trading volume. The optimal combination of market and ensemble forecasts gave zero weight to the market, meaning it added no useful information. The authors also flagged ethical concerns about hosting public health predictions on betting platforms.
How to grade a probability honestly
A forecast of 70 percent is neither right nor wrong on its own. Proper scoring rules reward both sharpness (confidence) and calibration (statistical truth). Move the slider, flip the outcome, and see how the Brier and log scores respond.
Reliability diagram (calibration)
Brier
Mean squared error of probabilities. Decomposes into calibration plus sharpness minus uncertainty. Forgiving of single misses.
Log
Penalizes confident wrong calls severely (it goes to infinity as a forecast approaches certainty in the wrong direction). Sensitive to tail risk.
CRPS
Generalizes absolute error to full predictive distributions. The right choice for continuous targets such as bed census or scan volume.
What a whale does to a thin market
Smart and colleagues (2026) built an agent-based model of a binary market with traders of heterogeneous expertise, budgets, and learning rates. They found that a highly resourced trader can temporarily distort prices roughly in proportion to market share, and that herding or slow belief updates amplify the distortion. This simulation lets you reproduce that dynamic.
Price trajectory: crowd alone vs crowd plus whale
Why this is a healthcare concern, not a finance footnote
A hospital prediction market would be small by construction: a few dozen schedulers, radiologists, and managers, not millions of retail traders. That thinness is precisely the regime where a single motivated actor (or a well-meaning but wrong senior leader) can move the price far enough to mislead a staffing decision. Robustness testing with simulated whale trades belongs in any validation plan before a market touches a real roster.
From raw signal to decision support
Forecasting and market models are only as good as their inputs. The framework assumes de-identified historical operational data plus public signals, governed by HIPAA and institutional review.
| Dataset / source | Type | Contents | Access |
|---|---|---|---|
| CMS Hospital Compare & FFS | Public | Quality, readmissions, mortality, utilization | Free API, annual updates |
| State discharge databases | Public | Patient-level discharges, diagnoses, length of stay | Registration, yearly release |
| CDC FluSurv-NET, NNDSS | Public | Weekly influenza rates, notifiable disease counts | Open access (FluView, WONDER) |
| Hospital EHR (Epic, Cerner) | Proprietary | Real-time admissions, ED visits, transfers, orders | Internal, IRB and data-use agreements |
| MIMIC-IV / eICU | Research | De-identified ICU records, timestamps, vitals | Credentialed research use |
| IoT / bed sensors | Internal | Live occupancy, device logs, RFID | Private, via hospital IT |
| NOAA weather, flu trends | Public | External demand correlates | Free APIs, needs parsing |
| Vizient and similar | Proprietary | Multi-hospital benchmarks | License required |
Four-layer architecture
1. Data Ingestion
Real-time EHR events (HL7 / FHIR), batch scheduling logs, external API feeds. ETL enforces consistent time zones, formats, and identifiers.
2. Data Lake / Preprocessing
Centralized repository for raw and cleaned data, feature storage, historical queries, labeled by time, location, and metric.
3. Model Engine
Statistical forecasts plus the LMSR market maker as a microservice. Scheduled retraining and online updates. Outputs both forecasts and market probabilities.
4. Dashboard / Visualization
Interactive UI with forecasts, confidence bands, market prices, alerts, and what-if controls that feed scenarios back to the engine.
Proving it works before it touches a roster
A market or forecast that has not been validated is a liability. The plan combines quantitative accuracy with qualitative human-factors testing, all under ethical and regulatory guardrails.
Quantitative validation
- Backtesting. Reconstruct archived market prices or simulate AMM trades, then compare implied distributions to actual outcomes.
- Walk-forward cross-validation. Rolling-origin evaluation that respects temporal order: train to time t, forecast t+1 onward, repeat across folds.
- Metrics. MAE, RMSE, MAPE, and scale-free MASE for points; Brier, log, and CRPS for probabilities; coverage and Winkler for intervals.
- Robustness. Inject noise and simulate whale trades (tab 06) to test susceptibility to manipulation.
Controlled deployment
- A/B pilots. Split by department: some units see forecasts and adjust staffing, others follow usual practice. Compare throughput and satisfaction.
- Human-factors testing. Usability studies with real managers to confirm the dashboard aids rather than confuses.
- Business KPIs. Congestion rate, wait-time reduction, and utilization measure the downstream impact that stakeholders care about.
Ethics, privacy, and regulation
Betting on health outcomes raises regulatory and professional concerns. Prefer an internal market using reputation points or departmental credits, not real money.
All patient data complies with HIPAA and IRB review. Public dashboards show only aggregated, de-identified forecasts.
Test whether forecasts are equally accurate across patient subgroups and mitigate algorithmic bias from unrepresentative training data.
A twelve-month research timeline
Iterative by design, with preliminary results by mid-project so the team can adapt market parameters and dashboard design before committing to a field trial.
Literature and data collection
Gather public and EHR-proxy datasets, define metrics, run stakeholder interviews to refine dashboard requirements.
Baseline modeling
Implement ARIMA and machine-learning forecasts for chosen operational metrics, build the ETL pipeline, begin backtesting.
Prediction market prototype
Stand up an LMSR market simulation or expert pilot, develop the first dashboard mockup.
Integration and testing
Combine market output with statistical forecasts, run cross-validation, evaluate calibration of the combined forecast.
Field testing and refinement
Deploy to a limited user group, run a controlled trial or case study, analyze performance against control.
Documentation and dissemination
Finalize analyses, prepare journal and conference papers, plan validation in additional settings.
References
Citations follow the attributions in the source research framework. Bracketed markers in the framework document map to the works above. Where a 2026 source could not be independently verified, it is presented as cited in the framework rather than as an established publication.